Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Steroid hormone intermediate company: Saito Bio will achieve operating income of 913 million yuan in 2020
— Share —

Steroid hormone intermediate company: Saito Bio will achieve operating income of 913 million yuan in 2020

healthoo 2021-04-20
Shandong Saito Biotechnology Co., Ltd. announced its 2020 results on April 20: 2020 is a very challenging year for Saito Bio.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.